IL10 and systemic sclerosis: The human counterpart of murine IL-10-producing B cells was significantly increased after an injection of alloBM-MSCs in severe SSc patients, either in all recipients or in patients with clinical improvement. Moreover, it was described as the increase of CD24hiCD27pos memory B-cell frequency and the increase of IL10 expression by B cells.